Assessment of PI3K/AKT and MAPK/ERK pathways activation in oral lymphatic malformations.
Oral Surg Oral Med Oral Pathol Oral Radiol
; 133(2): 216-220, 2022 02.
Article
en En
| MEDLINE
| ID: mdl-34753699
ABSTRACT
OBJECTIVE:
Lymphatic malformations are characterized by the overgrowth of lymphatic vessels during development. Activation of PI3K/AKT and MAPK/ERK signaling pathways occur in isolated lymphatic malformation and in those associated with syndromes such as CLOVES and Klippel-Trenaunay. We aimed to assess the activation of these pathways in sporadic oral lymphatic malformations. STUDYDESIGN:
A convenience sample of 14 formalin-fixed paraffin-embedded samples of oral lymphatic malformations underwent immunohistochemical reactions for the phosphorylated forms of AKT1 (pAKT-Ser473) and ERK1/2 (pERK1/2-Thr202/Tyr204), which are markers of PI3K/AKT and MAPK/ERK pathways activation, respectively.RESULTS:
Positive staining for pAKT1 and pERK1/2 was observed in the endothelial cells in all samples of oral lymphatic malformations evaluated.CONCLUSIONS:
Our results suggest that activation of PI3K/AKT and MAPK/ERK signaling pathways participates in the pathogenesis of oral lymphatic malformations.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Fosfatidilinositol 3-Quinasas
/
Sistema de Señalización de MAP Quinasas
/
Vasos Linfáticos
Límite:
Humans
Idioma:
En
Revista:
Oral Surg Oral Med Oral Pathol Oral Radiol
Año:
2022
Tipo del documento:
Article
País de afiliación:
Brasil